| Literature DB >> 24704983 |
Aurora Ruiz-Herrera1, Francisca Garcia2, Montserrat Garcia-Caldés3.
Abstract
Ionizing radiation damages DNA and induces mutations as well as chromosomal reorganizations. Although radiotherapy increases survival among cancer patients, this treatment does not come without secondary effects, among which the most problematic is gonadal dysfunction, especially in women. Even more, if radio-induced DNA damage occurs in germ cells during spermatogenesis and/or oogenesis, they can produce chromosomal reorganizations associated with meiosis malfunction, abortions, as well as hereditary effects. However, most of our current knowledge of ionizing radiation genotoxic effects is derived from in vitro studies performed in somatic cells and there are only some experimental data that shed light on how germ cells work when affected by DNA alterations produced by ionizing radiation. In addition, these few data are often related to mammalian males, making it difficult to extrapolate the results to females. Here, we review the current knowledge of radiobiology and reproduction, paying attention to mammalian females. In order to do that, we will navigate across the female meiotic/reproductive cycle/life taking into account the radiation-induced genotoxic effects analysis and animal models used, published in recent decades.Entities:
Year: 2012 PMID: 24704983 PMCID: PMC3899996 DOI: 10.3390/genes3030521
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Schematic representation of the radiation experiments in vivo performed in mammalian females considering the folliculogenesis/oocyte stage, the irradiation dose and the parameters analyzed.
Summary of the results of genotoxic effects of ionizing irradiation on experimental models.
| Species studied | Meiotic/Oocyte stage and irradiation dose | Parameters analyzed | Summary of results | Reference |
|---|---|---|---|---|
| mouse | Adult females | Locus-specific mutation at F1 | (−) | [ |
| 63 rads | ||||
| mouse | Ovaries | Cell killing | LD50: 0.15 Gy | [ |
| 0.15 Gy | Fertility | Maximum 4 litters/female; | ||
| Early follicles RS > Larger follicles RS | ||||
| mouse | Mature and immature oocytes | Dominant lethality (pre and post-implantation mortality) | RS species and oocyte stage-dependent | [ |
| 100-400 rads | ||||
| mouse | Pre-ovulatory oocytes | Chromosomal aberrations at MII | (+) | [ |
| 22-600 rads | Mature oocyte RS > Immature oocyte RS | |||
| Adult females | Chromosomal aberrations at: | |||
| 0.22, 0.66, 2 and 6 Gy | • MII | (+) | ||
| • 2-cell embryo | (+) | |||
| • 13.5-day embryo | (−) | |||
| mouse | Mature and immature oocytes | Chromosomal aberrations at MI | Mature oocyte RS >Immature oocyte RS | [ |
| 50-400 rads | ||||
| mouse | Immature oocytes | Chromosomal aberrations at dictionema | (−) | [ |
| 400 rads | ||||
| mouse | Pre-ovulatory oocytes | Chromosomal non-disjunction at MI | (+) At higher dose | [ |
| 0.05-0.80 Gy | ||||
| Structural chromosome aberrations at MII | (+) | |||
| mouse | Adult females | Dominant lethality | (+) | [ |
| 108-504 rads | Developmental malformations | (+) | ||
| Immature oocyte RS > Mature oocyte RS | ||||
| mouse | Juvenile mice | Primordial oocyte killing | LD50: 6-7 rads | [ |
| 6 and 7 rads | ||||
| mouse | Oocytes at dictionema | Chromosomal aberrations at one-cell embryos | (+) | [ |
| 100-600 cGy | ||||
| mouse | Pre-ovulatory oocytes | Chromosomal aberrations at MI | (+) | [ |
| ≤100 cGy | ||||
| mouse | Zygote stage | F1 chromosomal aberrations and micronuclei | (+/−) | [ |
| 2Gy | ||||
| mouse | Immature oocytes | Chromosomal aberrations at MII | (+) | [ |
| 0.1 and 0.2 Gy | ||||
| mouse | Fetal oocytes at 14, 16, and 17 days of gestation | SC anomalies at pachynema | Fragmentation stage-dependent | [ |
| 2 Gy | ||||
| mouse | Pre-implantation stage | Developmental malformations | (+) | [ |
| ≤3 Gy | LD100: 0.5 Gy | |||
| Oocytes within 1-4 weeks before ovulation | Developmental malformations | (+) | ||
| 2 and 3 Gy | ||||
| mouse | Pre-ovulatory oocytes | Chromosomal aberrations at: | [ | |
| 1-4 Gy | • MII | (+) | ||
| • pre-implantation stages | (+) | |||
| • post-implantation stages | (−) | |||
| mouse | Pre-implantation stage (2 h, 48 h, 72 and 96 h post-conception) | Developmental malformations and mortality | (+) | [ |
| RS irradiation stage-dependent | ||||
| 0.1-2.5 Gy | ||||
| mouse | Female zygote stage | Fertility alterations | (+) | [ |
| 1 Gy | F1 developmental malformations | (+) | ||
| mouse | Female zygote stage | Fertility alterations | (−) | [ |
| 0.2 and 0.4 Gy | F1 developmental malformations | (−) | ||
| Trans-generational genomic instability (chromosomal aberrations) | ||||
| (−) | ||||
| mouse | Pre-conception stage | Developmental malformations | (+) dose-dependent | [ |
| 1, 2.8, and 3 Gy | ||||
| Zygote stage | Developmental malformations | (+) dose-dependent | ||
| 1, 2.8, and 3 Gy | ||||
| Pre-implantation stage | Developmental malformations | (+) dose-dependent | ||
| 1, 2.8, and 3 Gy | ||||
| Zygote | Trans-generational genome instability (chromosomal aberrations) | (+) | ||
| 500 mGy, 1,000 mGy and 2,000 mGy | ||||
| mouse | Post-implantation stage | Trans-generational genome instability (ESTR mutation frequencies) | (−) | [ |
| 1 Gy | ||||
| mouse | Pre-conception stage | Trans-generational genome instability (polymorphism of DNA fragments) | (+) tissue-dependent | [ |
| 0.5, 1 and 2 Gy | ||||
| mouse | Adult female | Transgenerational genome instability (ESTR mutation frequencies) | (−) | [ |
| 1 Gy | ||||
| golden hamster | Mature and immature oocytes | Dominant lethality (pre and post-implantation mortality) | RS species and oocyte stage-dependent | [ |
| 100-400 rads | ||||
| guinea pig | Mature and immature oocytes | Dominant lethality (pre and post-implantation mortality) | RS species and oocyte stage-dependent | [ |
| 100-400 rads | ||||
| guinea pig | Mature and immature oocytes4 Gy | Dominant lethality (embryo mortality) | Mature oocyte RS > Immature oocyte RS | [ |
| guinea pig | Oogonia and oocytes at leptonema | Fertility | (−) | [ |
| 2 and 4 Gy | ||||
| Oocytes at birth and at adulthood | Cell-killing | LD50: 4 Gy | ||
| Fertility | (−) | |||
| 2 and 4 Gy | ||||
| One-cell embryo stage | Developmental malformations | (+) | ||
| 10, 50 and 100 cGy | ||||
| Oocytes at birth | Chromosomal aberrations at MI | Mature oocyte RS > Immature oocyte RS | ||
| 1 and 2 Gy | Nearly mature guinea pig oocyte RS > Nearly mature mouse oocyte RS | |||
| guinea pig | Oocytes at different stages of folliculogenesis | Chromosomal aberrations | Immature but grown oocyte RS < Maturing oocyte RS < Mature oocyte RS | [ |
| 4.0 Gy | ||||
| RS of guinea pig oocyte ≠ RS of mouse oocyte | ||||
| Chinese hamster | Oocytes around ovulation | Chromosomal aberrations at diakinesi stage | (+) | [ |
| 2 Gy | mouse oocyte RS = 2 × Chinese hamster oocyte RS | |||
| Chinese hamster | Oocytes at pachynema | Cell-killing | RS meiotic stage-dependent | [ |
| 1 Gy | ||||
| Oocytes at diplonema-dictionema | Cell-killing | LD100: 1 Gy | ||
| 1 Gy | ||||
| Oocytes at pachynema and diplonema-dictionema | Developmental malformations | (−) | ||
| Chromosomal aberrations at 1-cell embryos | ||||
| 1 Gy | (−) | |||
| rat | Ovary | Cell-killing | Primordial germ cell reduction (66%) | [ |
| 1 Gy | ||||
| rat | Ovary | Cell-killing | LD50: 1 Gy | [ |
| 1 Gy | ||||
| rat | Oogonia, oocytes at leptonema and zygonema | SC anomalies at pachynema | Fragmentation stage-dependent | [ |
| Cell killing | ||||
| 1, 2 and 5 Gy | (+) dose-dependent | |||
| rat | Immature oocytes of pre-pubertal and post-pubertal females | Fertility alterations | Pre-pubertal oocyte RS < Post-pubertal oocyte RS (−) | [ |
| SC alterations of F1 female fetuses | ||||
| 1, 2 and 5 Gy | ||||
| rat | Primordial follicle oocytes | Fertility alterations | (−) | [ |
| 5 Gy | F1 constitutional chromosomal aberrations | (−) | ||
| Trans-generational genome instability | (+) | |||
| Trans-generational sensitivity to chemical mutagen | Increased |
RS: radiation sensitivity; LD: lethal dose; SC: synaptonemal complex; Gy: Grey; F1: progeny of the irradiated female, MI: metaphase I, MII: metaphase II; (+): the parameter analyzed is affected by ionizing radiation; (−): the parameter analyzed is not affected by ionizing radiation.
Figure 2Comparison between genetic radiation-sensitivity observed in mouse and Guinea pig females.